Skip to Main Content

Author Details

Steven E Feldon
Flaum Eye Institute, University of Rochester
1977
146
37
PMIDPaper TitleJournal TitlePublished Year
36728631Evaluation of Optic Disc Edema in Long-Duration Spaceflight Crewmembers Using Retinal Photography.J Neuroophthalmol2023
37390454Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.J Clin Endocrinol Metab2023
34487739Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.Surv Ophthalmol2022
36048826TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy.PLoS One2022
35295218More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular Disease.Front Toxicol2022
34753601Re: Fairless et al.: Ophthalmology departments remain among the least diverse clinical departments at United States medical schools (Ophthalmology. 2021;128:1129-1134).Ophthalmology2022
32659311COVID-19 and the Ophthalmology Match.Ophthalmology2021
33507228MicroRNA-130a Is Elevated in Thyroid Eye Disease and Increases Lipid Accumulation in Fibroblasts Through the Suppression of AMPK.Invest Ophthalmol Vis Sci2021
34967836Variability of Retinal Vessel Tortuosity Measurements Using a Semiautomated Method Applied to Fundus Images in Subjects With Papilledema.Transl Vis Sci Technol2021
33242498Efficacy of Visual Retraining in the Hemianopic Field after Stroke: Results of a Randomized Clinical Trial.Ophthalmology2021
33230035Rehabilitation of cortically induced visual field loss.Curr Opin Neurol2021
32439897The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts.Sci Rep2020
31949093Retinal vessel diameter changes after 6 months of treatment in the Idiopathic Intracranial Hypertension Treatment Trial.Br J Ophthalmol2020
33347461Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.PLoS One2020
32832216A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells.Transl Vis Sci Technol2020
31536596Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor.PLoS One2019
31527897The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology.PLoS One2019
31622470TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts.Invest Ophthalmol Vis Sci2019
30662977Probability of Success in the Ophthalmology Residency Match: Three-Year Outcomes Analysis of San Francisco Matching Program Data.J Acad Ophthalmol (2017)2018
30081012The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.Am J Ophthalmol2018
28040526The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.Am J Ophthalmol2017
28973273Current Shortcomings of Camera Screening.JAMA Intern Med2017
25719380Axial Globe Position Measurement: A Prospective Multicenter Study by the International Thyroid Eye Disease Society.Ophthalmic Plast Reconstr Surg2016
27842700The Aryl Hydrocarbon Receptor and Its Ligands Inhibit Myofibroblast Formation and Activation: Implications for Thyroid Eye Disease.Am J Pathol2016
27423312Integrating the Internship into Ophthalmology Residency Programs: Association of University Professors of Ophthalmology American Academy of Ophthalmology White Paper.Ophthalmology2016
26886893Author Response: Choroidal Folds in Astronauts.Invest Ophthalmol Vis Sci2016
25538236Salinomycin and other polyether ionophores are a new class of antiscarring agent.J Biol Chem2015
26335066Retinal and Choroidal Folds in Papilledema.Invest Ophthalmol Vis Sci2015
26024112Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.Invest Ophthalmol Vis Sci2015
25416548Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn.FASEB J2015
24253217The immunopathology of giant cell arteritis: diagnostic and therapeutic implications.J Neuroophthalmol2014
25245083Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells.Exp Eye Res2014
25370513Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.Invest Ophthalmol Vis Sci2014
25370510Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.Invest Ophthalmol Vis Sci2014
24739993The idiopathic intracranial hypertension treatment trial: design considerations and methods.J Neuroophthalmol2014
24756514Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.JAMA2014
24756302The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.JAMA Neurol2014
24135759Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.Invest Ophthalmol Vis Sci2013
21959369Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study.Ophthalmology2012
22868639Lemierre syndrome causing bilateral cavernous sinus thrombosis.J Neuroophthalmol2012
22178289Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring.Exp Eye Res2012
20924305Reply re: "Sinus opacification associated with exacerbation of thyroid eye disease".Ophthalmic Plast Reconstr Surg2011
21571679Ocular fibroblast diversity: implications for inflammation and ocular wound healing.Invest Ophthalmol Vis Sci2011
21750423Coup de sabre presenting with worsening diplopia and enophthalmos.Ophthalmic Plast Reconstr Surg2011
21406171The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiation.Am J Pathol2011
21454487Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.J Biol Chem2011
20308056Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease.J Biol Chem2010
20502367Sinus opacification associated with exacerbation of thyroid eye disease.Ophthalmic Plast Reconstr Surg2010
20554910Novel anti-adipogenic activity produced by human fibroblasts.Am J Physiol Cell Physiol2010
20204067Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.PPAR Res2010
  • 1 - 50 of 146

Recommended Authors

Weill Cornell Medicine/New York Presbyterian Hospital
Career Start Year 2012
Number of shared co-authors 3
University of Washington
Career Start Year 2011
Number of shared co-authors 1
Gavin Herbert Eye Institute, University of California Irvine
Career Start Year 2009
Number of shared co-authors 3
Rigshospitalet-Glostrup Valdemar Hansens Vej 1-23
Career Start Year 2009
Number of shared co-authors 0
Samson Assuta Ashdod Hospital, Ben-Gurion University of the Negev
Career Start Year 2008
Number of shared co-authors 0
Michigan William Beaumont Hospital
Career Start Year 2006
Number of shared co-authors 1
Medstar Georgetown University Hospital
Career Start Year 2006
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 2006
Number of shared co-authors 0
Ibn Sina Hospital
Career Start Year 2004
Number of shared co-authors 1
Near East University
Career Start Year 2003
Number of shared co-authors 0
Wills Eye Hospital
Career Start Year 2001
Number of shared co-authors 3
University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
University of Washington
Career Start Year 1999
Number of shared co-authors 0
Royal Victoria Infirmary
Career Start Year 1999
Number of shared co-authors 0
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1999
Number of shared co-authors 1
Singapore Eye Research Institute
Career Start Year 1997
Number of shared co-authors 1
University of Minnesota Department of Ophthalmology and Visual Neurosciences
Career Start Year 1997
Number of shared co-authors 3
University of Alabama at Birmingham
Career Start Year 1996
Number of shared co-authors 3
University of California San Diego
Career Start Year 1993
Number of shared co-authors 0
Vanderbilt Eye Institute, Vanderbilt University
Career Start Year 1990
Number of shared co-authors 2
University of California San Diego
Career Start Year 1988
Number of shared co-authors 0
From the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1986
Number of shared co-authors 4
Mayo Clinic College of Medicine
Career Start Year 1984
Number of shared co-authors 4
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 1982
Number of shared co-authors 0
Department of Neurology and NYU Grossman School of Medicine
Career Start Year 1982
Number of shared co-authors 3
University of Pittsburgh
Career Start Year 1977
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1976
Number of shared co-authors 1
Feinberg School of Medicine, Northwestern University
Career Start Year 1970
Number of shared co-authors 2
Einhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai
Career Start Year 1969
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1965
Number of shared co-authors 1

Collaborators

Edward Harness Eye Center Columbia University Irving Medical Center
Co-authored papers 4
University of British Columbia
Co-authored papers 3
Carl Zeiss Meditec Inc.
Co-authored papers 2
Flaum Eye Institute, University of Rochester Medical Center
Co-authored papers 2
University of Wisconsin-Madison
Co-authored papers 2
Center for Space Medicine, Baylor College of Medicine
Co-authored papers 2
Co-authored papers 2
The University of Oklahoma Health Sciences Center
Co-authored papers 1
Bascom Palmer Eye Institute, University of Miami
Co-authored papers 1
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 1
University of Illinois at Chicago
Co-authored papers 1
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
University of Minnesota Medical School
Co-authored papers 1
Spencer Center for Vision Research, Byers Eye Institute, Stanford University
Co-authored papers 1
University of Rochester Medical Center
Co-authored papers 1
Bascom Palmer Eye Institute
Co-authored papers 1